Patent · US Active

Process for making 5,11-Dihydro-11-ethyl-5-methyl-8{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-di pyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one

US7282583B2 · kind B2 · utility

0Cited by

4References

16Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Saeed Ahmad · Swift Creek Farms, US
Robert Boswell · Richmond, US
Jack D. Brown · Moseley, US
Cary Mark Davis · Richmond, US
Kai Donsbach · Hargesheim, DE
Bernard Franklin Gupton · Midlothian, US
Christopher P. Johnson, III · Richmond, US
Ahmad Khodabocus · Richmond, US
Vithalanand R. Kulkarni · Petersburg, US
Young S. Lo · Hockessin, US

Key dates

Filing date	Nov 16, 2006
Grant date	Oct 16, 2007
Priority date	—
Expiry date	Nov 16, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

An improved process for making 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6H-di pyrido[3,2-b:2′,3′-e][1,4]diazepin-6-one.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.